Services by partner need
One intelligence platform. Five tailored pathways.
Every stakeholder sees a different part of the cancer journey. Dr PreZiGen connects those perspectives through one evidence framework and the right human expertise.
AI intelligence × Human judgement
Evidence-linked · Patient-specific · Expert-reviewed
Choose the path that fits your need
Start with who you are. We will guide the next step.
- Healthcare Practitioners Patient-specific interpretation and expert consultation.
- Hospitals & Cancer Centres Virtual MTB and scalable centre-of-excellence workflows.
- Patients & Families Clear explanations for informed conversations with care teams.
- Diagnostic Centres Clinical-context interpretation that adds value to NGS.
- Biopharma Companies Biomarker strategy, education and responsible adoption.
Core capabilities
What sits behind every pathway
-
Test strategy
Which tests may add information, and what they can and cannot tell you.
-
Report interpretation
Molecular and pathology reports explained in clinical context.
-
AI–HI review
AI-assisted evidence organisation with accountable expert judgement.
-
Second opinion
An independent, evidence-linked perspective for the treating team.
-
Virtual MTB
Structured multidisciplinary molecular tumor board discussion.
-
Longitudinal review
Tracking diagnosis, therapy, response and resistance over time.
Secure case workflow
Not sure which pathway fits?
Tell us a little about your situation and we'll point you to the right starting point.
Secure · Clinical documents are uploaded only after you sign in to the portal